NEW YORK (GenomeWeb News) – Vermillion today reported $361,000 in fourth quarter revenues, down from $1.6 million in Q4, 2014.

However, due to the way in which revenues were reported under the company's previous agreement with Quest Diagnostics, the two quarters are not directly comparable, the firm said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.